BMS-599626
An orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors.
Product Specifications
Shipping Conditions
RT
Storage Conditions
-20°C
Shelf Life
24months
More Discoveries
Explore Other Products
Browse additional items from our catalog
